Canine renal failure syndrome in three dogs

Three dead dogs were brought to the College of Veterinary Medicine, Kyungpook National University for study. Clinically, all the dogs showed emaciation, anorexia, depression, hemorrhagic vomiting and diarrhea for 7~10 days before death. All the clinical signs were first noted for about one month after feeding the dogs with commercial diets. At necropsy, all 3 dogs had severe renal damage with the same green-yellowish colored nephroliths in the renal pelvis. They also showed systemic hemorrhage and calcification of several organs, which might have been induced by uremia. Microscopically, necrosis, calcification and calculi were detected in the renal tubules, and especially in the proximal convoluted tubules and collecting ducts of the kidney. These findings were supportive of a mycotoxic effect, and especially on their kidneys. However, the precise cause of the toxic effect in these cases of canine renal failure could not be determined.     

猪繁殖与呼吸综合征病毒NVDC-JXA1株膜基质蛋白单克隆抗体的研制

为制备抗猪繁殖与呼吸综合征病毒NVDC-JXA1株单克隆抗体,用纯化的猪繁殖与呼吸综合征病毒NVDC-JXA1株免疫BALB/c小鼠,最后一次免疫后第3天取其脾细胞与SP2/0细胞在聚乙二醇作用下融合,通过酶联免疫吸附试验（ELISA）和间接免疫荧光试验（IFA）筛选,以有限稀释法克隆3次,制备单克隆抗体,并对制备的单克隆抗体进行鉴定。结果表明获得了2株分泌PRRSV膜基质蛋白特异性抗体的杂交瘤细胞,命名为1D12、5H5,经鉴定其抗体亚型分别为IgG2b、IgM,2株均为κ链,腹水ELISA效价分别为1∶107和1∶105。该单克隆抗体与PRV、PPV、PCV、CSFV、JEV无交叉反应。作者成功制备了抗猪繁殖与呼吸综合征病毒NVDC-JXA1株膜基质蛋白单克隆抗体,为进一步建立相关诊断方法奠定了基础。     

羊传染性脓疱病的流行及诊治

本文主要对羊传染性脓疤病在我国的流行病学、临床症状、病理变化、诊断和防治等方面进行了概述,以便对该病的诊断和防治提供参考。     

两种细度测量仪对羊毛纤维直径测定的对比分析

为了检验国产动物纤维细度自动测量仪奥达2000的稳定性和准确性,分别用进口的OFDA100细度仪和国产动物纤维细度自动测量仪对来自314只细毛羊的毛样进行测定,再对两者测得的数据作配对性t检验。检验结果表明,二者间差异不显著（P>0.05）。因此,国产动物纤维细度自动测量仪奥达2000性能与OFDA100细度仪没有差异,可以代替进口细度仪OFDA100。     

抗猪瘟免疫球蛋白在猪初乳中变化规律研究

以猪瘟弱毒疫苗免疫空怀母猪,待母猪分娩后,分别收集10d内的乳汁,以建立的间接ELISA法检测猪瘟IgA、IgG、IgM水平,并观察各种抗体动态变化规律。试验结果表明,猪初乳中的IgA、IgG、IgM抗体效价均在分娩当天达到最高值,随后迅速下降,7d后抗体水平与常乳基本一致(>0.05)。对照组母猪仅在分娩当天检测到较低的抗体水平。     

口蹄疫病毒VP1基因密码子偏好性分析

VP1蛋白是口蹄疫病毒(FMDV)的主要结构蛋白,可诱导机体产生中和抗体以及激发保护性免疫应答。为探究VP1基因密码子偏好性,筛选出其最佳体外表达系统,使用Visual Gene Developer、CodonW、GraphPad Prism等软件,对VP1基因进行密码子偏好性分析,同时将VP1基因密码子使用频率与大肠杆菌、毕赤酵母、昆虫杆状病毒和哺乳动物细胞表达系统作了比较。结果显示,VP1基因的CAI为0.21,ENC为55.43,GC3S为65.26%,表明该基因密码子使用偏好较弱并且密码子偏好以G/C碱基结尾。结合VP1基因与各表达系统密码子使用频率比值,发现其与昆虫杆状病毒表达系统频率比值差异最小且CAI最大,因此推断昆虫杆状病毒表达系统是FMDV VP1基因最适体外表达系统。本研究为FMDV亚单位疫苗研制等提供了技术基础。     

迪卡配套系猪RYR1的PCR分析及其利用的研究

试验从鸡东县永安猪场随机抽取迪卡配套系猪B系和E系42头，通过PCR扩增技术和酶切鉴定．采用克隆技术进行测序，来检测是否含有氟烷基因序列。经过以上技术检测这42头猪均没有氟烷基因。     

1株H5N1亚型高致病力禽流感病毒人工感染鸭的抗原定位观察

通过对鸭静脉接种或眼-鼻-口腔-泄殖腔接种禽流感病毒A/duck/Guangdong/220/2004(H5N1)后,采用免疫组织化学方法检查病毒核蛋白抗原,探讨了该病毒在组织器官中的定位与分布.结果表明,病毒核蛋白抗原主要存在于鸭的心肌细胞、肝细胞、枯否氏细胞、胰腺泡上皮细胞、肾小管上皮细胞、血管内皮细胞和血液吞噬性自细胞;在气管和支气管黏膜上皮,脑组织,肠黏膜上皮,胸腺、法氏囊、脾脏和肺脏的巨噬细胞或组织细胞以及坏死的细胞碎片中也可检查到少量病毒核蛋白抗原;而在食管、胃、睾丸、卵巢、甲状腺、肾上腺、哈德氏腺、骨骼肌等未检查到该抗原.     

中国原生犬保护随想

我们知道,中国的动植物遗传资源保护形势严峻,在当今中国的生态资源几近崩溃的今天我们来讨论中国原生犬的保护,不知道为什么,我的心情十分沉重.     

Protective efficacy of a live attenuated Mycoplasma hyopneumoniae vaccine with an ISCOM-matrix adjuvant in pigs

An attenuated Mycoplasma hyopneumoniae vaccine that requires intrathoracic administration is commercially available for use against mycoplasmal pneumonia in China. Given the limitations of such a route of administration, this study was undertaken to assess the capacity of an ISCOM-matrix adjuvant to enhance immunogenicity following intramuscular use. Immune responses in pigs following vaccination and subsequent intra-tracheal bacterial inoculation were examined using lymphocyte proliferation, serology and mucosal IgA in both nasal and saliva swabs.Vaccination induced clear lymphocyte proliferation, but only slight serum antibody responses although these were significantly increased following experimental infection. Mucosal IgA was not detected in either nasal or salivary secretions. Following bacterial challenge, animals vaccinated with the adjuvant-containing live vaccine exhibited less severe pulmonary lesions (median score 3.67) than unvaccinated pigs (median score 13.58). The degree of ciliary loss on the respiratory tract surface was reduced in vaccinated pigs compared with experimentally infected controls. The findings indicated that the adjuvant vaccine administered IM provided protection against experimentally induced mycoplasmal pneumonia and could have commercial potential.